Freeze-drying works in stages. The product is first frozen solid, then placed under a vacuum so the frozen water sublimates directly from solid to vapor without passing through a liquid phase. A secondary drying step removes residual bound moisture. The result is a dry cake or powder. Storage and reconstitution handling are specified in the insert supplied with the lot.
For a clinic, the practical difference between a lyophilized and a cryopreserved format is primarily logistics. Confirm with the supplier whether a specific lyophilized product tolerates room-temperature storage or requires refrigeration, based on that product's own stability data, since this is not uniform across every lyophilized product. The documented storage requirement affects what equipment a clinic needs to budget for, how much inventory it can hold on a shelf, and how staff are trained to reconstitute the product correctly before use.
Because freeze-drying is a manufacturing step rather than a category of product, buyers should still request the same baseline documentation they would for any format: the certificate of analysis for the specific lot, the reconstitution instructions in the product insert, and any stability data the supplier has generated supporting the stated shelf life.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice. For lyophilized exosome products specifically, FDA states no FDA-approved exosome products exist. Such products are generally regulated as biologic drugs under section 351, and purchase and clinical-use decisions belong to the physician together with their own regulatory counsel.
Knowing whether a product is lyophilized affects what storage equipment a clinic needs, how much inventory it can carry, and what reconstitution training staff require before a lot can be used.